Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. - Wikidata - wikimedia - TriplyDB

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.

http://www.wikidata.org/entity/Q44842989

about

Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Pancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence Review Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Tissue engineering approaches to cell-based type 1 diabetes therapy Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia Control of IBMIR in neonatal porcine islet xenotransplantation in baboons Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago.Islet cell transplant: Update on current clinical trials.First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotra Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.Awards in Transplantation Science Recognize the Best Manuscripts Published in Transplantation.Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes.Benefits of Islet Transplantation as an Alternative to Pancreas Transplantation: Retrospective Study of More Than 10 Ten Years of Experience in a Single Center.Oxygen-permeable microwell device maintains islet mass and integrity during shipping.Transplantation sites for human and murine islets.Long-term cultured neonatal islet cell clusters demonstrate better outcomes for reversal of diabetes: in vivo and molecular profiles.Human islet cells are killed by BID-independent mechanisms in response to FAS ligand.The Pathobiology of Diabetes Mellitus

P2860

Q26752205-1D864F82-860B-453B-952C-BF350E943418 Q26769878-4241C597-0F66-4848-8315-13F586F26527 Q26773701-48795660-4FBB-4A78-9048-065E2C7FD632 Q26779812-F28380EE-913C-4B48-8B70-3B3951ADF698 Q26823090-88C60C7A-2B65-4D37-9086-9159DFCE460F Q26862805-6F2A8FE6-198A-4F9A-B535-CF7461B23085 Q28049693-FBF72EC9-096C-4EFA-A789-1E831B858662 Q34376068-D7303FDE-9314-4E1E-865B-9F2DBF290066 Q35630711-C584F23F-3B3A-4806-9B5D-2FFA1A57F62D Q37346582-5BDF192B-83C1-4654-AFFB-EED98BEE053E Q38689971-3EB4CD39-4B89-47B8-842C-62F726B17C47 Q38751293-14F86D86-B347-4196-A510-D9B1A67602D0 Q39444068-A8D15007-91B8-487D-A8A4-97FCF79573AE Q42063562-8F7851D5-3EBC-45F9-8690-027DB08C22F6 Q45205309-7B77C6ED-7654-4CE2-8B86-7E0BE64EA7AA Q47282972-4105B8D0-1295-487A-B9CF-BFAC669B91C3 Q52684486-35745BCF-0196-4DA3-A3E1-403E4C849217 Q53148123-7C08B279-717B-4F5C-9B28-B5B1CBC26650 Q53610765-9B543B1E-109D-400A-BC2A-FF5B5B68EB4F Q53642353-77027506-6CB7-4811-AC93-307CFB2575A9 Q58316252-5619912A-0829-4E80-9E3E-6E5341CE585C

P2860

Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.

http://www.wikidata.org/entity/Q44842989

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Multicenter Australian trial o ...... ng accessibility and outcomes.

@en

Multicenter Australian trial o ...... ng accessibility and outcomes.

@nl

type

label

Multicenter Australian trial o ...... ng accessibility and outcomes.

@en

Multicenter Australian trial o ...... ng accessibility and outcomes.

@nl

prefLabel

Multicenter Australian trial o ...... ng accessibility and outcomes.

@en

Multicenter Australian trial o ...... ng accessibility and outcomes.

@nl

P1433

Q44842989-4958773E-9234-4F84-8BBD-1C86F943134D

P1476

Q44842989-97B3045D-05BF-4322-8FD3-62D269AEC690

P2093

Q44842989-13931199-56C6-461C-A1A1-784582F5B87B

Q44842989-1E777ECE-4C5C-42C1-93D8-F6F4592F6D13

Q44842989-209F0BD3-ABF2-424C-9787-57E752DF65E8

Q44842989-2D2E89A8-84E5-46FB-9ED5-629602A96A3D

Q44842989-35069986-C646-4082-9F51-5A61730A376F

Q44842989-3A6695FA-577A-4B13-A413-A00412D9DCB2

Q44842989-50C1CAEF-6608-48CA-B41B-AC050E446D3F

Q44842989-66D6FEF0-20D2-4DCD-A1F5-81859A9F56CD

Q44842989-933D9E29-FBA1-4E37-A320-BF9E4F410C1C

Q44842989-9EABECB0-017F-4C40-9839-152A20310D06

P2860

Q44842989-013FC673-AF9B-4681-998E-ED3DDD75366B

Q44842989-15BC3AE2-229F-46AC-AA47-6B9244D007A3

Q44842989-2C2BC169-F9BE-4D27-A701-D5DCEBED7B67

Q44842989-3213EDD2-DF51-4D37-ACC2-CBFE4A5EFFA9

Q44842989-3EB3D389-230F-4646-808F-1B937EFD5DCE

Q44842989-40B989BA-C663-43FF-B902-7E6CEAED83AF

Q44842989-410B3EF7-1037-4669-B7B6-CAD81ADC3A3C

Q44842989-49AF3F9A-9549-4020-A6D4-CD7E7AF30D8F

Q44842989-4A7AD70A-1A69-4A3B-B6D5-5A3CA9BB2395

Q44842989-604BB9DF-BDD8-4907-AA07-93D4A12C0817

P304

Q44842989-39589EBA-4FCD-4DE6-BE99-4B7456A32823

P31

Q44842989-06F9F4CB-35B6-4B6C-A3A8-EC8EAE2C05A9

P356

Q44842989-FB8D5A29-725C-4035-9073-628FEAE527B6

P407

Q44842989-F24511BA-212C-4603-A186-945253CD28DA

P433

Q44842989-5F7423D8-767A-495C-B6CC-6DD3CDB5E50C

P478

Q44842989-ADAB4D83-8A9C-4DB4-AC58-44A35A2C926F

P577

Q44842989-39491487-6FC0-4B56-8488-30ED0AF9F330

P698

Q44842989-0564613E-51F2-4E11-B93A-1195573EF104

P356

P1433

American Journal of Transplantation

P1476

Multicenter Australian trial o ...... ng accessibility and outcomes.

@en

P2093

Australian Islet Transplant Consortium

http://www.w3.org/2001/XMLSchema#string

C J Drogemuller

http://www.w3.org/2001/XMLSchema#string

D Goodman

http://www.w3.org/2001/XMLSchema#string

D J Holmes-Walker

http://www.w3.org/2001/XMLSchema#string

D J Torpy

http://www.w3.org/2001/XMLSchema#string

G M Ward

http://www.w3.org/2001/XMLSchema#string

H E Thomas

http://www.w3.org/2001/XMLSchema#string

J E Gunton

http://www.w3.org/2001/XMLSchema#string

P J O'Connell

http://www.w3.org/2001/XMLSchema#string

P T Coates

http://www.w3.org/2001/XMLSchema#string

P2860

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Improvement in outcomes of clinical islet transplantation: 1999-2010.

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

Five-year follow-up after clinical islet transplantation.

Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

Islet isolation assessment in man and large animals.

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.

Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.

P304

1850-1858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12250

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23668890

http://www.w3.org/2001/XMLSchema#string